MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字HJ20181146

April 9, 2024

H20181146

Drug Information

盐酸奥洛他定滴眼液

帕坦洛

眼用制剂

0.1% (5ml: 5mg,按C₂₁H₂₃NO₃计)

化学药品

April 9, 2024

April 8, 2029

Company Information

Applicant Company

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

Manufacturing Company

s. a. alcon couvreur n. v.

Rijksweg 14, B-2870, Puurs, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥洛他定滴眼液 - NMPA 批准文号 | MedPath